Literature DB >> 16935000

The dynamics of natural killer cell tolerance.

Maria H Johansson1, Petter Höglund.   

Abstract

Natural killer (NK) cells are important mediators of resistance against tumor growth and metastasis. NK cell reactivity is regulated by a balance of signals from activating and inhibitory receptors. While reactivity against tumor cells is beneficial, it is essential that NK cells do not attack normal tissue. The distinction between tumor cells and normal cells is partly made at the level of activating receptors: transformation often results in induction of ligands for such receptors. In addition, NK cells discriminate self from non-self using MHC class I-binding inhibitory receptors. Host MHC class I molecules regulate development of NK cell reactivity and tolerance, a process that is not well understood. Recent data suggest that functional maturation may not be a binary phenomenon: quantitative aspects, with regards to avidity and frequency in interactions between developing NK cells and normal cells, may be important for the generation of NK cells that are 'tuned' to optimally sensing the absence of self-MHC class I. In this article, we discuss models for development of NK cell reactivity and tolerance. Our understanding of this process may have significant implications for the use of NK cells in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935000     DOI: 10.1016/j.semcancer.2006.07.013

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  4 in total

1.  Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness.

Authors:  Djem U Kissiov; Michele Ardolino; Nataliya Tovbis Shifrin; Nathalie T Joncker; David H Raulet
Journal:  J Immunol       Date:  2016-10-19       Impact factor: 5.422

2.  Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas.

Authors:  Anna Kruschinski; Andreas Moosmann; Isabel Poschke; Håkan Norell; Markus Chmielewski; Barbara Seliger; Rolf Kiessling; Thomas Blankenstein; Hinrich Abken; Jehad Charo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

3.  Use of natural killer cells as immunotherapy for leukaemia.

Authors:  Bartosz Grzywacz; Jeffrey S Miller; Michael R Verneris
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

Review 4.  Natural killer cells and their role in rheumatoid arthritis: friend or foe?

Authors:  Hamid Shegarfi; Fatemeh Naddafi; Abbas Mirshafiey
Journal:  ScientificWorldJournal       Date:  2012-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.